Uroflowmetry Parameters in Patients Undergoing Artificial Urinary Sphincter Implantation.

IF 2.3 Q3 UROLOGY & NEPHROLOGY
Advances in Urology Pub Date : 2025-08-18 eCollection Date: 2025-01-01 DOI:10.1155/aiu/9995075
Hisanori Taniguchi, Sho Kiyota, Nae Takizawa, Hidefumi Kinoshita
{"title":"Uroflowmetry Parameters in Patients Undergoing Artificial Urinary Sphincter Implantation.","authors":"Hisanori Taniguchi, Sho Kiyota, Nae Takizawa, Hidefumi Kinoshita","doi":"10.1155/aiu/9995075","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objectives:</b> The study aims to determine the uroflowmetry parameters of patients undergoing artificial urinary sphincter (AUS) implantation. Hence, uroflowmetry results pre- and post-AUS implantation and differences according to patient background were evaluated. <b>Methods:</b>Thirty-five patients who underwent primary AUS implantation for severe stress urinary incontinence due to radical prostatectomy were enrolled. All patients underwent uroflowmetry tests before and 1, 3, 6, and 12 months after AUS device activation. The patients reported outcomes using validated questionnaires: the King's Health Questionnaire (KHQ), the International Prostate Symptom Score (IPSS), and the quality of life (QOL) score. <b>Results:</b> The mean patient age was 72.8 ± 5.4 years. The mean maximum flow rate (<i>Q</i> <sub>max</sub>) value pre-AUS implantation (20.4 ± 11.3 mL/s) was significantly higher at 1-month post-AUS implantation and maintained at 12 months (26.0 ± 14.7 mL/s; <i>p</i>=0.011). KHQ, IPSS, and QOL scores were significantly improved after AUS implantation. <i>Q</i> <sub>max</sub>, and voiding volume was significantly higher in patients aged < 73 years compared to those aged ≥ 73 years. <b>Conclusion:</b> Uroflowmetry parameters were improved after AUS implantation and maintained for at least 12 months. Not only subjective outcomes but also objective outcomes of uroflowmetry parameters significantly improved after AUS implantation. This is the first report assessing uroflowmetry outcomes after AUS implantation.</p>","PeriodicalId":7490,"journal":{"name":"Advances in Urology","volume":"2025 ","pages":"9995075"},"PeriodicalIF":2.3000,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377952/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/aiu/9995075","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The study aims to determine the uroflowmetry parameters of patients undergoing artificial urinary sphincter (AUS) implantation. Hence, uroflowmetry results pre- and post-AUS implantation and differences according to patient background were evaluated. Methods:Thirty-five patients who underwent primary AUS implantation for severe stress urinary incontinence due to radical prostatectomy were enrolled. All patients underwent uroflowmetry tests before and 1, 3, 6, and 12 months after AUS device activation. The patients reported outcomes using validated questionnaires: the King's Health Questionnaire (KHQ), the International Prostate Symptom Score (IPSS), and the quality of life (QOL) score. Results: The mean patient age was 72.8 ± 5.4 years. The mean maximum flow rate (Q max) value pre-AUS implantation (20.4 ± 11.3 mL/s) was significantly higher at 1-month post-AUS implantation and maintained at 12 months (26.0 ± 14.7 mL/s; p=0.011). KHQ, IPSS, and QOL scores were significantly improved after AUS implantation. Q max, and voiding volume was significantly higher in patients aged < 73 years compared to those aged ≥ 73 years. Conclusion: Uroflowmetry parameters were improved after AUS implantation and maintained for at least 12 months. Not only subjective outcomes but also objective outcomes of uroflowmetry parameters significantly improved after AUS implantation. This is the first report assessing uroflowmetry outcomes after AUS implantation.

Abstract Image

Abstract Image

Abstract Image

人工尿道括约肌植入术患者的尿流测量参数。
目的:研究人工尿括约肌(AUS)植入术患者的尿流测量参数。因此,评估aus植入前后尿流测量结果及患者背景差异。方法:35例根治性前列腺切除术后严重压力性尿失禁患者行AUS植入术。所有患者在AUS装置激活前、激活后1、3、6和12个月进行尿流测定。患者使用经过验证的问卷报告结果:国王健康问卷(KHQ)、国际前列腺症状评分(IPSS)和生活质量评分(QOL)。结果:患者平均年龄72.8±5.4岁。aus植入后1个月的平均最大流速(Q max)值(20.4±11.3 mL/s)明显高于aus植入前1个月,12个月维持在26.0±14.7 mL/s; p=0.011)。AUS植入后,KHQ、IPSS、QOL评分均显著提高。结论:AUS植入后尿流测量参数得到改善,并维持至少12个月。AUS植入后,无论是主观结果还是客观结果均有明显改善。这是第一份评估AUS植入后尿流测量结果的报告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in Urology
Advances in Urology UROLOGY & NEPHROLOGY-
CiteScore
2.90
自引率
0.00%
发文量
17
审稿时长
15 weeks
期刊介绍: Advances in Urology is a peer-reviewed, open access journal that publishes state-of-the-art reviews and original research papers of wide interest in all fields of urology. The journal strives to provide publication of important manuscripts to the widest possible audience worldwide, without the constraints of expensive, hard-to-access, traditional bound journals. Advances in Urology is designed to improve publication access of both well-established urologic scientists and less well-established writers, by allowing interested scientists worldwide to participate fully.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信